grant

Selective serotonin re-uptake inhibitors (SSRIs) and osteoporosis: Mechanisms and clinical consequences [ 2011 - 2014 ]

Also known as: Selective serotonin re-uptake inhibitors (SSRIs) and osteoporosis

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1009367]

Researchers: A/Pr Lana Williams (Principal investigator) ,  Dr Jason Hodge

Brief description Selective serotonin re-uptake inhibitors (SSRIs) are commonly used to treat depression. Serotonin is not unique to the brain but is also used by other cells in the body, including bone cells. In this project the influence of SSRIs on human osteoclast and osteoblast formation and function will be investigated in a laboratory. Additionally, the impact of SSRI use on bone loss and fracture risk in a community sample of women and men will be investigated. These studies will determine if exposure to SSRIs adversely impact bone health.

Funding Amount $AUD 422,964.09

Funding Scheme Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]